1007-3418
2013 Issue 10
Clinical recommendations to address malnutrition in patients with end-stage liver diseases
DUAN Zhong-ping
DUAN Zhong-ping
..............page:721-722
Effect of hepatitis B virus X protein on suppressor of cytokine signaling-1 expression
SONG Xiao-ling;LIU Guo-zhen;TAN De-ming;LI Yan-yan
SONG Xiao-ling;LIU Guo-zhen;TAN De-ming;LI Yan-yan
..............page:723-727
Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma
LI Zhen;ZHOU Jin-xue;REN Jian-zhuang;ZHANG Wen-jing;HAN Xin-wei
LI Zhen;ZHOU Jin-xue;REN Jian-zhuang;ZHANG Wen-jing;HAN Xin-wei
..............page:728-733
Prevalence of nutritional risk among in-patients with liver diseases in Beijing,China
guo hui min ; zhou li ; ma wen chen ; zhu yan tao ; wang yan ; wang jing ; sun xiao ling ; zhang chang qing ; duan zhong ping
guo hui min ; zhou li ; ma wen chen ; zhu yan tao ; wang yan ; wang jing ; sun xiao ling ; zhang chang qing ; duan zhong ping
..............page:734-738
Enhanced nutritional therapy may promote wound healing after endoscopic therapy in patients with liver cirrhosis and esophageal varices
LI Chang-zheng;LI Qing-shan;LI Xue;YAN Jun-hong;WANG Rui-ling;JIANG Ren-xiu
LI Chang-zheng;LI Qing-shan;LI Xue;YAN Jun-hong;WANG Rui-ling;JIANG Ren-xiu
..............page:739-742
Risk factors of hepatorenal syndrome in patients with acute on chronic liver failure
ZHANG Dong-qing;CHEN Li;GAN Qiao-rong;LIN Qing-feng;PAN Chen
ZHANG Dong-qing;CHEN Li;GAN Qiao-rong;LIN Qing-feng;PAN Chen
..............page:743-746
Synergistic action of 4-hydroxynonenal and tumor necrosis factor involving the NF-κB/IκBα signaling pathway in alcohol-induced liver injury
DU Zhong-yan;GAO Jia;WANG Wei-xi;YU Chen-hui;DOU Xiao-bing
DU Zhong-yan;GAO Jia;WANG Wei-xi;YU Chen-hui;DOU Xiao-bing
..............page:747-752
Expression of aquaporin 3 and aquaporin 9 is regulated by oleic acid through the PI3K/Akt and p38 MAPK signaling pathways
GU Lu-yun;QIU Lie-wang;CHEN Xiao-feng;L(U) Lin;MEI Zhe-chuan
GU Lu-yun;QIU Lie-wang;CHEN Xiao-feng;L(U) Lin;MEI Zhe-chuan
..............page:753-758
Protective effect of recombinant TM-N and recombinant soluble RAGE in a mouse model of acute hepatic failure
HUANG Shao-fang;WU Fei;LIU Wei;HE Yong-wen
HUANG Shao-fang;WU Fei;LIU Wei;HE Yong-wen
..............page:759-763
Effects of antihistamine treatment on immune fuction in rats with experimental hepatitis
LI Hong;ZHAO Long-feng;HAO Yan-qin;HAN De-wu
LI Hong;ZHAO Long-feng;HAO Yan-qin;HAN De-wu
..............page:764-768
Effect of enteral nutrition therapy in patients with decompensated liver cirrhosis
ZHANG Shu-qin;SUN Hai-ying
ZHANG Shu-qin;SUN Hai-ying
..............page:769-771
Four-year follow-up of two end-stage hepatitis B cases following transplantation of HBsAg-positive donor liver graft
jiao zuo yi ; zhang dong hong ; yang jia yin ; xu ming qing ; wang wen tao ; zeng yong ; li bo ; yan lv nan
jiao zuo yi ; zhang dong hong ; yang jia yin ; xu ming qing ; wang wen tao ; zeng yong ; li bo ; yan lv nan
..............page:771-773
Fibrosis-related differential expression and upstream mechanisms of beta-arrestin in the carbon tetracholoride-induced liver fibrosis mouse model
SUN Hui-ling;GE Yu-li;CHEN Yong-ping
SUN Hui-ling;GE Yu-li;CHEN Yong-ping
..............page:773-775
Effects of Cichorium glandulosum Boiss.et Huet.on expression of fibronectin, Smad3, IGFBP-rP1, and TGFβ1 in a liver fibrosis rat model
QIN Dong-mei;HU Li-ping;NIE Ya-ru;CHEN Wen
QIN Dong-mei;HU Li-ping;NIE Ya-ru;CHEN Wen
..............page:776-777
Protective effects and mechanisms of 1,25(OH)2D3 on diabetes-induced liver injury in a streptozotocin-diabetic rat model
ZHAO Xiao-qiang;QUAN Li;DU Guo-li;XIAO Shan;L(U) Wen-kui;ZHU Jun
ZHAO Xiao-qiang;QUAN Li;DU Guo-li;XIAO Shan;L(U) Wen-kui;ZHU Jun
..............page:778-780
Emergenceof entecavirgenotypic resistancein a nucleoside-na(i)vechronic hepatitis B patient who had been treated for nearly five years: a case report
LIU Fen;WANG Xi-wei
LIU Fen;WANG Xi-wei
..............page:781-782
A case report of sustained virological response with PEG-interferon-α-2b in a patient with CML and hepatitis C prior fail in ten-year treatment of conventional interferon
LUO Wen-fan;PENG Jie
LUO Wen-fan;PENG Jie
..............page:783-784
A case report of hepatic graft versus host disease histologically resembling autoimmune hepatitis
ZENG Da-wu;DONG Jing;LIU Yu-rui;JIANG Jia-ji
ZENG Da-wu;DONG Jing;LIU Yu-rui;JIANG Jia-ji
..............page:784-786
Primary liver paraganglioma:a case report
CHEN Ping;ZHAI Ya-nan;LIU Hong;WANG Hao;GUO Shun-lin
CHEN Ping;ZHAI Ya-nan;LIU Hong;WANG Hao;GUO Shun-lin
..............page:786-787
Hepatocellular carcinoma risk and hepatitis B virus mutations
WANG Hui;GAO Chun-fang
WANG Hui;GAO Chun-fang
..............page:788-792
Update of FOXP3 and chronic liver diseases
ZHANG Hong-wei;YAO Dong-mei
ZHANG Hong-wei;YAO Dong-mei
..............page:792-795
Recent progress in research of biomarkers of acute kidney injury in liver cirrhosis
PU Chun-wen;WANG Bing-yuan;QIAO Liang;PU Chun-yang
PU Chun-wen;WANG Bing-yuan;QIAO Liang;PU Chun-yang
..............page:796-798
A brief report on the 5th National Congress of Fatty Liver Disease and 2013 Frontiers Medical Forum in China
CAO Hai-xia;FAN Jian-gao;SHI Jun-ping;LI You-ming;ZHUANG Hui
CAO Hai-xia;FAN Jian-gao;SHI Jun-ping;LI You-ming;ZHUANG Hui
..............page:799-800